Horizon Discovery Group PLC operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Horizon Discovery Group PLC with three other
pharmaceutical manufacturers in Europe:
Eczacibasi Ilac Sanayi ve T.A.S.
sales of 692.09 million Turkish Liras [US$118.12 million]
of which 80%
New Nordic Healthbrands AB
(393.71 million Swedish Kronor [US$40.13 million]
Moberg Pharma AB (publ)
based in Sweden
(439.04 million Swedish Kronor [US$44.75 million]
of which 40%
was Kerasal Nail /Nalox).
Horizon Discovery Group PLC reported sales of £58.73 million (US$74.35 million)
December of 2018.
increase of 60.9%
versus 2017, when the company's sales were £36.51 million.
Sales at Horizon Discovery Group PLC have increased during each of the previous five years
(and since 2013, sales have increased a total of 784%).
Sales of Products saw an increase
102.8% in 2018, from
£22.82 million to £46.28 million.
Not all segments of Horizon Discovery Group PLC experienced an increase in sales in 2018:
sales of Services fell 20.6% to £10.87 million.